Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group

Infants (<1 year old) with acute myeloid leukemia (AML) are particularly vulnerable to intensive cytotoxic therapy. Indeed, the mortality rate was high among infants enrolled in the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study, which prompted us to temporarily suspend patient enr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomizawa, Daisuke, Tawa, Akio, Watanabe, Tomoyuki, Saito, Akiko Moriya, Kudo, Kazuko, Taga, Takashi, Iwamoto, Shotaro, Shimada, Akira, Terui, Kiminori, Moritake, Hiroshi, Kinoshita, Akitoshi, Takahashi, Hiroyuki, Nakayama, Hideki, Kiyokawa, Nobutaka, Isoyama, Keiichi, Mizutani, Shuki, Hara, Junichi, Horibe, Keizo, Nakahata, Tatsutoshi, Adachi, Souichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101778/
https://www.ncbi.nlm.nih.gov/pubmed/24068655
http://dx.doi.org/10.1007/s12185-013-1429-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101778/
https://www.ncbi.nlm.nih.gov/pubmed/24068655
http://dx.doi.org/10.1007/s12185-013-1429-2

Ejemplares similares